Cargando…

Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private Insurers

IMPORTANCE: Despite epidemic rates of addiction and death from prescription opioids in the United States, suggesting the importance of providing alternatives to opioids in the treatment of pain, little is known regarding how payers’ coverage policies may facilitate or impede access to such treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heyward, James, Jones, Christopher M., Compton, Wilson M., Lin, Dora H., Losby, Jan L., Murimi, Irene B., Baldwin, Grant T., Ballreich, Jeromie M., Thomas, David A., Bicket, Mark C., Porter, Linda, Tierce, Jonothan C., Alexander, G. Caleb
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2018
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324451/ https://www.ncbi.nlm.nih.gov/pubmed/30646222 http://dx.doi.org/10.1001/jamanetworkopen.2018.3044

Ejemplares similares

Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers
por: Lin, Dora H., et al.
Publicado: (2018)

Association between US Pharmacopeia (USP) monograph standards, generic entry and prescription drug costs
por: Murimi-Worstell, Irene B., et al.
Publicado: (2019)

Analysis of State Insurance Coverage for Nonpharmacologic Treatment of Low Back Pain as Recommended by the American College of Physicians Guidelines
por: Bonakdar, Robert, et al.
Publicado: (2019)

Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis
por: Murimi-Worstell, Irene B, et al.
Publicado: (2020)

Indication-Specific Opioid Prescribing for US Patients With Medicaid or Private Insurance, 2017
por: Mikosz, Christina A., et al.
Publicado: (2020)

Trends of Prescription Drug Manufacturer Rebates in Commercial Health Insurance Plans, 2015-2019
por: Plummer, Elizabeth, et al.
Publicado: (2022)

Coverage of genetic therapies for spinal muscular atrophy across fee-for-service Medicaid programs
por: Ballreich, Jeromie, et al.
Publicado: (2022)

Examining gender differentials and determinants of private health insurance coverage in Zambia
por: Mulenga, James, et al.
Publicado: (2021)

Assessing Resource Use in Oncology Patients
por: Semroc, Georgette N., et al.
Publicado: (2003)

Out-patient coverage: Private sector insurance in India
por: Gambhir, Ramandeep S., et al.
Publicado: (2019)

Prognosis in Women with Breast Cancer and Private Extra Insurance Coverage
por: Grau, Juan J., et al.
Publicado: (2013)

Estimating & comparing greenhouse gas emissions for existing intramuscular COVID-19 vaccines and a novel thermostable oral vaccine
por: Patenaude, Bryan, et al.
Publicado: (2022)

Modeling the potential economic benefits of an oral SARS-CoV-2 vaccine during an outbreak of COVID-19
por: Patenaude, Bryan, et al.
Publicado: (2022)

Private health insurance coverage of drug use disorder treatment: 2005–2018
por: Mojtabai, Ramin, et al.
Publicado: (2020)

Branded prescription drug spending: a framework to evaluate policy options
por: Ballreich, Jeromie, et al.
Publicado: (2017)

Opportunities and Challenges of Generic Pre-Exposure Prophylaxis Drugs for HIV
por: Ballreich, Jeromie, et al.
Publicado: (2022)

Private Health Insurance Plans in 1977: Coverage, Enrollment, and Financial Experience
por: Carroll, Marjorie Smith, et al.
Publicado: (1979)

Consequences on Private Insurance Coverage: The AAOS Clinical Practice Guidelines and Hyaluronic Acid Injections
por: Vangsness, C. Thomas, et al.
Publicado: (2020)

Trends in opioid and non-opioid treatment for chronic non-cancer pain and cancer pain among privately insured adults in the United States, 2012–2019
por: Bandara, Sachini, et al.
Publicado: (2022)

Consider expenditure controls’ impacts on equity
por: Frick, Kevin D, et al.
Publicado: (2021)

Utilization of Filgrastim and Infliximab Biosimilar Products in Medicare Part D, 2015-2019
por: Hussaini, S. M. Qasim, et al.
Publicado: (2022)

PIN150 Economic VALUE of Treatment and Vaccine Technologies to Address the COVID-19 Pandemic: A Cost-Effectiveness and Budget IMPACT Analysis
por: Padula, W., et al.
Publicado: (2020)

Nonpharmacological interventions in COPD
por: Janssens, Wim, et al.
Publicado: (2023)

Paying for Drugs After the Medicare Part D Beneficiary Reaches the Catastrophic Limit: Lessons on Cost Sharing from Other US Policy Partnerships Between Government and Commercial Industry
por: Padula, William V., et al.
Publicado: (2018)

Provider and Patient Characteristics of Medicare Beneficiaries Who Are High-Risk for COVID-19 Mortality
por: Ballreich, Jeromie, et al.
Publicado: (2021)

Determinants of Health Insurance Coverage among People Aged 45 and over in China: Who Buys Public, Private and Multiple Insurance
por: Jin, Yinzi, et al.
Publicado: (2016)

Private Health Insurance Flans in 1978 and 1979: A Review of Coverage, Enrollment, and Financial Experience
por: Carroll, Marjorie Smith, et al.
Publicado: (1981)

How public and private health insurance coverage mitigates catastrophic health expenditures in Republic of Korea
por: Jung, Hyun Woo, et al.
Publicado: (2022)

Allocation of National Institutes of Health Funding by Disease Category in 2008 and 2019
por: Ballreich, Jeromie M., et al.
Publicado: (2021)

Nonpharmacological Therapies for Atrial Fibrillation
por: Caldwell, Jane C., et al.
Publicado: (2011)

Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US
por: Ballreich, Jeromie, et al.
Publicado: (2020)

The Effects of Private Health Insurance on Universal Health Coverage Objectives in China: A Systematic Literature Review
por: Wu, Runguo, et al.
Publicado: (2020)

Nonpharmacological treatment of epilepsy
por: Saxena, V. S., et al.
Publicado: (2011)

Association between early nonpharmacological management and follow-up for low back pain in the veterans health administration
por: Coleman, Brian C., et al.
Publicado: (2023)

What Fraction of Medicaid Enrollees Have Private Insurance Coverage at the Time of Enrollment? Estimates from Administrative Data
por: Dague, Laura, et al.
Publicado: (2014)

Out-of-pocket spending for oral contraceptives among women with private insurance coverage after the Affordable Care Act()()
por: Frederiksen, Brittni, et al.
Publicado: (2020)

New Proposal of Private Insurance Program for Dementia Patients: Design of Sustainable Private Insurance Program in Korea
por: Park, Kun-Woo, et al.
Publicado: (2017)

Nonpharmacologic Interventions in Prevention and Treatment of Hypertension
por: Erejuwa, Omotayo O., et al.
Publicado: (2019)

Nonpharmacological treatments for anxiety disorders
por: Cottraux, Jean
Publicado: (2002)

Nonpharmacological prevention of osteoporotic fractures
por: Kessenich, Cathy R
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_hmjs7kagkimkvk54oo22bmbvua